{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:34:39Z","timestamp":1787636079401,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014480","name":"Horizon Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jbspin.2024.105704","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T16:46:00Z","timestamp":1707324360000},"page":"105704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Early-onset gout"],"prefix":"10.1016","volume":"91","author":[{"given":"Tristan","family":"Pascart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ducoulombier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Jauffret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2024.105704_bib0295","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2024.105704_bib0300","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0305","first-page":"27","article-title":"Gout: state of the art after a decade of developments","volume":"58","author":"Pascart","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2024.105704_bib0310","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jbspin.2015.01.002","article-title":"Hyperuricemia starts at 360 micromoles (6mg\/dL)","volume":"82","author":"Bardin","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2024.105704_bib0315","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/acr.22660","article-title":"Prevalence of gout in the adult population of France","volume":"68","author":"Bardin","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2024.105704_bib0320","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105704_bib0325","doi-asserted-by":"crossref","first-page":"e000326","DOI":"10.1136\/rmdopen-2016-000326","article-title":"Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective","volume":"2","author":"Kapetanovic","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2024.105704_bib0330","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination survey, 2007\u20132016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0335","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2478\/jtim-2022-0031","article-title":"Prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in mainland China","volume":"10","author":"Song","year":"2022","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.jbspin.2024.105704_bib0340","first-page":"301","article-title":"Trends in hyperuricemia and gout prevalence: nutrition and health survey in Taiwan from 1993\u20131996 to 2005\u20132008","volume":"20","author":"Chuang","year":"2011","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.jbspin.2024.105704_bib0345","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14397595.2020.1784556","article-title":"Real-world treatment of gout and asymptomatic hyperuricemia: a cross-sectional study of Japanese health insurance claims data","volume":"31","author":"Koto","year":"2021","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0350","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/gucdd1040018","article-title":"Gout in paleopathology: a review with some etiological considerations","volume":"1","author":"Ling","year":"2023","journal-title":"Gout, Urate, and Crystal Deposition Disease"},{"key":"10.1016\/j.jbspin.2024.105704_bib0355","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/rheumatology\/ker361","article-title":"National prevalence of gout derived from administrative health data in Aotearoa New Zealand","volume":"51","author":"Winnard","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2024.105704_bib0360","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(24)00012-3","article-title":"The gout epidemic in French Polynesia: a modelling study of data from the Ma\u2019i u\u2019u epidemiological survey","author":"Pascart","year":"2024","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.jbspin.2024.105704_bib0365","doi-asserted-by":"crossref","first-page":"105286","DOI":"10.1016\/j.jbspin.2021.105286","article-title":"Epidemiology of gout and hyperuricemia in New Caledonia","volume":"89","author":"Bardin","year":"2022","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2024.105704_bib0370","doi-asserted-by":"crossref","first-page":"k3951","DOI":"10.1136\/bmj.k3951","article-title":"Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts","volume":"363","author":"Major","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2024.105704_bib0375","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/art.42393","article-title":"Association of gout polygenic risk score with age at disease onset and tophaceous disease in european and polynesian men with gout","volume":"75","author":"Sumpter","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0380","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13075-019-2016-6","article-title":"Population-specific factors associated with fractional excretion of uric acid","volume":"21","author":"Narang","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2024.105704_bib0385","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1136\/annrheumdis-2012-202732","article-title":"Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load","volume":"72","author":"Dalbeth","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105704_bib0390","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2014-205877","article-title":"Twenty-eight loci that influence serum urate levels: analysis of association with gout","volume":"75","author":"Phipps-Green","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105704_bib0395","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/rheumatology\/kez685","article-title":"Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus","volume":"59","author":"Zaidi","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2024.105704_bib0400","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/15257770.2013.866679","article-title":"ABCG2 dysfunction increases the risk of renal overload hyperuricemia","volume":"33","author":"Matsuo","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.jbspin.2024.105704_bib0405","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/srep02014","article-title":"Common dysfunctional variants in ABCG2 are a major cause of early-onset gout","volume":"3","author":"Matsuo","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.jbspin.2024.105704_bib0410","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3390\/ijms22041935","article-title":"Identification of two dysfunctional variants in the ABCG2 urate transporter associated with pediatric-onset of familial hyperuricemia and early-onset gout","volume":"22","author":"Toyoda","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jbspin.2024.105704_bib0415","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kex295","article-title":"Functional non-synonymous variants of ABCG2 and gout risk","volume":"56","author":"Stiburkova","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2024.105704_bib0420","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41584-018-0040-6","article-title":"From hyperuricaemia to gout: what are the missing links?","volume":"14","author":"Liote","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0425","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/jcm9051295","article-title":"Association of specific comorbidities with monosodium urate crystal deposition in urate-lowering therapy-naive gout patients: a cross-sectional dual-energy computed tomography study","volume":"9","author":"Pascart","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jbspin.2024.105704_bib0430","doi-asserted-by":"crossref","first-page":"e003725","DOI":"10.1136\/rmdopen-2023-003725","article-title":"Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout","volume":"9","author":"Laurent","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2024.105704_bib0435","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/art.40572","article-title":"Brief report: monosodium urate monohydrate crystal deposits are common in asymptomatic sons of patients with gout: the sons of gout study","volume":"70","author":"Abhishek","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0440","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","article-title":"Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105704_bib0445","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/annrheumdis-2019-215521","article-title":"Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout","volume":"78","author":"Kawamura","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105704_bib0450","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/annrheumdis-2020-219796","article-title":"Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank","volume":"80","author":"Sandoval-Plata","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105704_bib0455","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3899\/jrheum.201684","article-title":"Aotearoa New Zealand Maori and Pacific population-amplified gout risk variants: CLNK is a separate risk gene at the SLC2A9 locus","volume":"48","author":"Ji","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0460","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13075-022-02917-4","article-title":"Polygenic risk score trend and new variants on chromosome 1 are associated with male gout in genome-wide association study","volume":"24","author":"Chang","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2024.105704_bib0465","doi-asserted-by":"crossref","first-page":"105364","DOI":"10.1016\/j.jbspin.2022.105364","article-title":"Trained immunity and inflammation in rheumatic diseases","volume":"89","author":"Badii","year":"2022","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2024.105704_bib0470","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/gucdd1030014","article-title":"Gout and cardiovascular disease: mechanisms, risk estimations, and the impact of therapies","volume":"1","author":"Andr\u00e9s","year":"2023","journal-title":"Gout, Urate, and Crystal Deposition Disease"},{"key":"10.1016\/j.jbspin.2024.105704_bib0475","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/gucdd1010004","article-title":"The gouty kidney: a reappraisal","volume":"1","author":"Bardin","year":"2023","journal-title":"Gout, Urate, and Crystal Deposition Disease"},{"key":"10.1016\/j.jbspin.2024.105704_bib0480","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","article-title":"Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options","volume":"15","author":"Bardin","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.jbspin.2024.105704_bib0485","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40744-023-00565-x","article-title":"Comparison between early-onset and common gout: a systematic literature review","volume":"10","author":"Amatucci","year":"2023","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jbspin.2024.105704_bib0490","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/acr.23706","article-title":"Patients with early-onset gout and development of earlier severe joint involvement and metabolic comorbid conditions: results from a cross-sectional epidemiologic survey","volume":"71","author":"Pascart","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2024.105704_bib0495","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League against rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105704_bib0500","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/acr2.11057","article-title":"Clinical characteristics of early-onset gout in outpatient setting","volume":"1","author":"Li","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0505","article-title":"Determinants of achieving serum urate goal with treat-to-target urate-lowering therapy in gout","author":"Helget","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0510","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/tpj.2015.101","article-title":"ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout","volume":"17","author":"Roberts","year":"2017","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jbspin.2024.105704_bib0515","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fphar.2016.00518","article-title":"Identification of Febuxostat as a new strong ABCG2 inhibitor: potential applications and risks in clinical situations","volume":"7","author":"Miyata","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0520","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/rheumatology\/key423","article-title":"No association between ATP-binding cassette transporter G2 rs2231142 (Q141K) and urate-lowering response to febuxostat","volume":"58","author":"Stamp","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2024.105704_bib0525","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1093\/rheumatology\/kead118","article-title":"Early-onset gout and rare deficient variants of the lactate dehydrogenase D gene","volume":"62","author":"Bardin","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2024.105704_bib0530","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3899\/jrheum.150181","article-title":"Severe tophaceous gout with radiograph examination of diffused calcified soft tissue tophi","volume":"42","author":"Oehler","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0535","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/art.42266","article-title":"Superiority of low-dose benzbromarone to low-dose febuxostat in a prospective, randomized comparative effectiveness trial in gout patients with renal uric acid underexcretion","volume":"74","author":"Yan","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0540","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jbspin.2020.05.002","article-title":"2020 recommendations from the French Society of Rheumatology for the management of gout: urate-lowering therapy","volume":"87","author":"Pascart","year":"2020","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2024.105704_bib0545","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105704_bib0550","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105704_bib0555","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/rheumatology\/kex150","article-title":"The British Society for Rheumatology guideline for the management of gout","volume":"56","author":"Hui","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2024.105704_bib0560","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/gucdd1010002","article-title":"Crystal Clear? The 2022 NICE guideline for the diagnosis and management of gout","volume":"1","author":"Dahanayake","year":"2023","journal-title":"Gout, Urate, and Crystal Deposition Disease"},{"key":"10.1016\/j.jbspin.2024.105704_bib0565","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4081\/reumatismo.2019.1176","article-title":"The Italian Society of Rheumatology clinical practice guidelines for the diagnosis and management of gout","volume":"71","author":"Ughi","year":"2019","journal-title":"Reumatismo"},{"key":"10.1016\/j.jbspin.2024.105704_bib0570","first-page":"sp-1","article-title":"Japanese Society of Gout and Uric; nucleic acids 2019 guidelines for management of hyperuricemia and gout 3rd edition","volume":"44","author":"Hisatome","year":"2020","journal-title":"Gout and Uric Nucleic Acids"},{"key":"10.1016\/j.jbspin.2024.105704_bib0575","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/1756-185X.14266","article-title":"2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout","volume":"25","author":"Lorenzo","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105704_bib0580","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/jch.14721","article-title":"Effects of the DASH diet and losartan on serum urate among adults with hypertension: results of a randomized trial","volume":"25","author":"Castilla-Ojo","year":"2023","journal-title":"J Clin Hypertens (Greenwich)"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X24000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X24000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T10:36:17Z","timestamp":1727692577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X24000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1297319X24000150"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2024.105704","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early-onset gout","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2024.105704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"105704"}}